| Entry |
|
|---|
| Name |
Clevudine (USAN) |
|---|
| Formula |
C10H13FN2O5
|
|---|
| Exact mass |
260.0809
|
|---|
| Mol weight |
260.22
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiviral, Reverse transcriptase inhibitor |
|---|
| Target |
HBV reverse transcriptase [KO: K21037] |
|---|
| Pathway |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF12 Clevudine
D03537 Clevudine (USAN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D03537 Clevudine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
D03537 Clevudine (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C1y C 16.6113 -17.4519
2 C1y C 17.0318 -18.7836
3 C1y C 18.4336 -18.7836
4 C1y C 18.8541 -17.4519
5 O2x O 17.7327 -16.6108
6 C1b C 15.2095 -17.0314
7 X F 19.2045 -19.9050
8 O1a O 16.1908 -19.9050
9 O1a O 14.1582 -17.9425
10 N4y N 20.0844 -16.7626
11 C8y C 21.2737 -17.4170
12 N4x N 22.4921 -16.7237
13 C8y C 22.4773 -15.2806
14 C8y C 21.3136 -14.6525
15 C8x C 20.0952 -15.3458
16 O5x O 21.2538 -18.7992
17 O5x O 23.6957 -14.5874
18 C1a C 21.3079 -13.2441
BOND 19
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 1 6 1 #Down
7 3 7 1 #Down
8 2 8 1 #Up
9 6 9 1
10 4 10 1 #Down
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 2
16 10 15 1
17 11 16 2
18 13 17 2
19 14 18 1
|
|---|
